enGene Holdings Inc. (ENGN) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-14
5:19 pm
Purchase
2026-06-3013GENGENE HLDGS INC
ENGN
Perceptive Advisors LLC6,899,803
9.990%
129,198increase
(+1.91%)
Filing
History
2026-08-14
4:49 pm
Sale
2026-06-3013GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.0
0.000%
-4,771,414decrease
(Position Closed)
Filing
History
2026-08-14
08:25 am
Sale
2026-06-3013GENGENE THERAPEUTICS INC
ENGN
Deep Track Capital, LP0
0.000%
-4,317,332decrease
(Position Closed)
Filing
History
2026-08-13
11:40 am
Purchase
2026-06-3013GENGENE THERAPEUTICS INC
ENGN
Invus Public Equities, L.P.6,256,662
9.300%
1,003,503increase
(+19.10%)
Filing
History
2026-08-12
4:31 pm
Sale
2026-06-3013GENGENE THERAPEUTICS INC
ENGN
Blue Owl Capital Holdings LP511,177
0.760%
-2,583,892decrease
(-83.48%)
Filing
History
2026-07-22
09:14 am
Purchase
2026-07-2013GENGENE HLDGS INC
ENGN
ACORN BIOVENTURES, L.P.3,357,282
5.000%
3,357,282increase
(New Position)
Filing
History
2026-05-15
1:12 pm
Sale
2026-03-3113GENGENE HLDGS INC
ENGN
Cormorant Asset Management, LP0
0.000%
-4,000,000decrease
(Position Closed)
Filing
History
2026-05-14
10:30 am
Purchase
2026-05-1213GENGENE HLDGS INC
ENGN
BML Investment Partners, L.P.6,669,908
9.950%
1,444,908increase
(+27.65%)
Filing
History
2026-05-13
9:23 pm
Purchase
2026-05-0813GENGENE HLDGS INC
ENGN
BML Investment Partners, L.P.5,225,000
7.800%
5,225,000increase
(New Position)
Filing
History
2026-05-05
10:59 am
Purchase
2026-03-3113GENGENE THERAPEUTICS INC
ENGN
Invus Public Equities, L.P.5,253,159
7.800%
1,008,600increase
(+23.76%)
Filing
History
2026-02-17
6:09 pm
Sale
2025-12-3113GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.4,771,414
7.100%
-275,000decrease
(-5.45%)
Filing
History
2026-02-17
3:00 pm
Purchase
2025-12-3113GENGENE HLDGS INC
ENGN
Cormorant Asset Management, LP4,000,000
5.970%
4,000,000increase
(New Position)
Filing
History
2026-02-17
12:46 pm
Sale
2025-12-3113GENGENE HLDGS INC
ENGN
Kynam Capital Management, LP1,492,898
2.230%
-3,501,192decrease
(-70.11%)
Filing
History
2026-01-27
2:18 pm
Purchase
2026-01-2113GENGENE HLDGS INC
ENGN
Invus Public Equities, L.P.4,244,559
6.300%
4,244,559increase
(New Position)
Filing
History
2025-11-18
4:01 pm
Purchase
2025-11-1113GENGENE HLDGS INC
ENGN
Deep Track Capital, LP4,317,332
6.690%
2,077,979increase
(+92.79%)
Filing
History
2025-11-18
4:00 pm
Purchase
2025-11-1113GENGENE HLDGS INC
ENGN
Perceptive Advisors LLC6,770,605
9.990%
6,770,605increase
(New Position)
Filing
History
2025-11-14
08:12 am
Sale
2025-09-3013GENGENE HLDGS INC
ENGN
Deep Track Capital, LP2,239,353
4.370%
-2,318,222decrease
(-50.87%)
Filing
History
2025-02-14
6:15 pm
Purchase
2024-12-3113GENGENE HLDGS INC
ENGN
Venrock Healthcare Capital Partners III, L.P.5,046,414
9.900%
1,480,573increase
(+41.52%)
Filing
History
2025-02-14
5:16 pm
Purchase
2024-12-3113GENGENE HLDGS INC
ENGN
Kynam Capital Management, LP4,994,090
9.800%
4,994,090increase
(New Position)
Filing
History
2025-02-14
2:25 pm
Sale
2024-09-3013GENGENE HLDGS INC
ENGN
Foresite Capital Fund VI LP0
0.000%
-2,500,000decrease
(Position Closed)
Filing
History
Goto 0, 1, 2, Next